E4 antibodies facilitate detection and type-assignment of active HPV infection in cervical disease.
High-risk human papillomavirus (HPV) infections are the cause of nearly all cases of cervical cancer. Although the detection of HPV DNA has proved useful in cervical diagnosis, it does not necessarily predict disease presence or severity, and cannot conclusively identify the causative type when mult...
Guardado en:
Autores principales: | Heather Griffin, Zhonglin Wu, Rebecca Marnane, Vincent Dewar, Anco Molijn, Wim Quint, Christine Van Hoof, Frank Struyf, Brigitte Colau, David Jenkins, John Doorbar |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1e1623690b7943f384e7754dffd52773 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Assessing survival rate of HPV-positive and HPV-negative cervical cancer patients
por: M. K. Ibragimova, et al.
Publicado: (2019) -
CERVICAL NEOPLASIA AND VIRUS LOAD OF HPV 16 GENOTYPE
por: V. S. Chirsky, et al.
Publicado: (2014) -
HPV Testing for Cervical Cancer in Romania: High-Risk HPV Prevalence among Ethnic Subpopulations and Regions
por: Minodora Bianca Ilisiu, et al.
Publicado: (2019) -
Six-month incidence and persistence of oral HPV infection in HIV-negative and HIV-infected men who have sex with men.
por: Sofie H Mooij, et al.
Publicado: (2014) -
Clinical performance of high-risk HPV testing on self-samples versus clinician samples in routine primary HPV screening in the Netherlands: An observational study
por: Federica Inturrisi, et al.
Publicado: (2021)